Parallel Bio

Drug Discovery · Cambridge, MA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to design and engineer tools to change the way diseases are cured. Parallel Bio is based in Cambridge, MA and was founded in 2020. It was valued at $71.5 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $24.6 million across 2 recorded rounds; the latest was a $20 million Series A1 in Jun 2025.

PMV mark · valuation
$71.5M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$24.6M
Last round
Later Stage VC (Series A1)
Jun 2025
How much has Parallel Bio raised?
$24.6Macross 2 recorded rounds · Dec 2022 – Jun 2025

Most recently, Parallel Bio raised $20.0M in its Later Stage VC (Series A1) (Jun 2025).

Free account
More of Parallel Bio with a free account
  • ·The complete investor list: 24 names
  • ·Watch Parallel Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Parallel Bio round by round

2 rounds
Jun 2025Later Stage VC (Series A1)$20.0M▮
+ 1 more investors · free account
Dec 2022Seed Round$4.3M▮
+ 1 more investors · free account

How much has Parallel Bio raised?

Parallel Bio has raised $24.6 million across 2 recorded rounds since 2022. The largest was a $4.3 million seed round in Dec 2022; the most recent was a $20 million Series A1 in Jun 2025.

Parallel Bio investors

24 investors are on record for Parallel Bio, including Y Combinator, Gaingels, Metaplanet Holdings and Asymmetry Ventures. By type, the record holds 7 venture capital firms and 1 family office. The Series A1 in Jun 2025 drew 7 investors.

For fundraisers
Raising for a company like Parallel Bio?

24 investors have backed Parallel Bio — start your target list with the firms already writing checks in drug discovery.

See all 24 investors →

Frequently asked about Parallel Bio

How much has Parallel Bio raised?
Parallel Bio has raised $24.6M in total across 2 recorded funding rounds.
When was Parallel Bio's last funding round?
Parallel Bio's most recent recorded round was Later Stage VC (Series A1) in Jun 2025, raising $20.0M.